Comparison of Brain Network Activation (BNA™) Analysis, Clinical Symptoms and Neuro-cognitive Performance in Concussed Children and Young Adults

September 23, 2019 updated by: ElMindA Ltd

Comparison of Brain Network Activation Analysis (BNA™) Using Evoked Response Potentials, Clinical Symptoms and Neuro-cognitive Performance and Symptoms in Concussed Children, Young Adults and Matched Controls

The use of Event Related Potentials (ERP) and neurocognitive performance in patients following concussion has been examined previously in small cohorts and relatively long after concussion occurred. However, little is known about the immediate changes in brain activity in specific brain regions and connectivity across them associated with performance on specific neurocognitive tests following a concussion, and the subsequent changes over time. The proposed study will provide initial evidence for the feasibility of an ERP based biomarker for concussion reflecting temporal and spatial changes in brain activity as well as brain functional connectivity associated with concussion.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

151

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15203
        • UPMC Sports Medicine Concussion Program

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 27 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Experimental subjects will include males and females with a recent sports-related concussion (less than 10 days post-concussion) recruited from approximately 50 high schools and colleges with UPMC-affiliated certified athletic trainers (ATC) on staff and from patients at the UPMC Sports Medicine Concussion Program.

Description

Inclusion Criteria:

  • Aged 14-27 years
  • Arm 1 only (Concussed): Over 2 days and below 10 days post-concussion (sports-related)
  • Currently symptomatic
  • Willingness to participate and able to give informed assent (child) and/or consent (parent for minors or adult 18+ years of age for self)

Exclusion Criteria:

  • TBI (i.e., Glasgow Coma Scale <13) or brain surgery
  • Any psychiatric disorder
  • Substance abuse
  • Special education
  • Any Neurological disorder
  • Any medication affecting CNS
  • Significant sensory deficits such as deafness or blindness
  • Clinically significant abnormal laboratory values or ECG
  • A history of more than 3 concussions in the past
  • A concussion within the last year
  • Residual symptoms or deficits related to a previous concussion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Concussed
Patients with recent concussion
Matched controls
Athletes with no recent concussion

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change of Brain Network Activation(BNA™)Scores Over Post Concussion Recovery Period
Time Frame: days 2-10, 7-19, 12-28, 17-37 following concussion
days 2-10, 7-19, 12-28, 17-37 following concussion

Secondary Outcome Measures

Outcome Measure
Time Frame
Correlation Of The Change In BNA™ Scores To Neurocognitive Tests Scores and Clinical Diagnostic
Time Frame: days 2-10, 7-19, 12-28, 17-37 following concussion
days 2-10, 7-19, 12-28, 17-37 following concussion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

ElMindA Ltd

Investigators

  • Principal Investigator: Anthony P. Kontos, Ph.D., UPMC Sports Medicine Concussion Program
  • Principal Investigator: Michael W. Collins, Ph.D., UPMC Sports Medicine Concussion Program

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2012

Primary Completion (Actual)

January 1, 2014

Study Completion (Actual)

March 1, 2014

Study Registration Dates

First Submitted

February 7, 2012

First Submitted That Met QC Criteria

February 9, 2012

First Posted (Estimate)

February 14, 2012

Study Record Updates

Last Update Posted (Actual)

September 25, 2019

Last Update Submitted That Met QC Criteria

September 23, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ELM-01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Traumatic Brain Injury

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe